HBI Deals+Insights / M&A/IPOs
Multiple sources tell HBI that UK, Czechia and Poland-based ophthalmology platform Optegra is for sale. We take a look at the detailed figures behind the prospective sale, speculate as to price and buyers, and speak to an operator source about his view of the business.